in3

in3

Details

EwC Role: 
Project Partner
Duration: 
1 Jan 2017 - 31 Dec 2021
Client: 
Marie Skłodowska-Curie Action - Innovative Training Network (H2020)

ABOUT THIS PROJECT

The Marie Skłodowska-Curie Innovative Training Network in3 aims to drive the synergistic development and utilisation of in vitro and in silico tools for human chemical and nanomaterial safety assessment. State-of-the-art human induced pluripotent stem cells research, cheminformatics, mechanistic toxicology and biokinetics are integrated safety assessment approaches. DC is hosting one of the 15 PhD students working on data management and integration, harmonization of analysis workflows and biomarker identification for key events of adverse outcome pathways. Recruitment for this and other positions in the network is still ongoing.

Latest Tweets

Edelweiss Connect (2 weeks ago)
RT @barryhardy: Cosmetics Assessment is an area with a strong need for use of non-animal testing methods and continuing innovation in testi…
Edelweiss Connect (2 weeks ago)
RT @barryhardy: Discussion of COVID-19 work using modelling and informatics 19 CEST, Tuesday 22 September, OpenTox 2020 virtual conference…
Edelweiss Connect (2 weeks ago)
Join us for the 2020 OpenTox Virtual Conference Sep 21-25 The OpenTox 2020 Conference activity will be supported b… https://t.co/azV6JH5sJI
Edelweiss Connect (2 months ago)
#SaferWorldbyDesign Use of alternative skin models for animal-free safety and efficacy testing in dermatology resea… https://t.co/I9wkhBRjZm
Edelweiss Connect (2 months ago)
RT @barryhardy: The activities of drug inactive ingredients on biological targets This #OpenTox Webinar (Thursday 8 August) will include a…

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA